The medical exoskeleton market size is projected to reach USD 1.0 billion by 2026, from USD 0.2 billion in 2021, at a CAGR of 45.0%.
Increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches.
Globally, the number of people with physical disabilities is increasing majorly due to the rising geriatric population, increasing number of road accidents and severe trauma injuries, and increasing prevalence of stroke, among other factors. According to the US Census Bureau, the global elderly population is estimated to increase at a steady pace in the coming years, from 703 million in 2019 to 1.5 billion by 2050.
With the rising geriatric population, the number of people with disabilities is increasing as the elderly are more prone to conditions such as stroke and severe musculoskeletal injuries resulting from falls. The significant growth in the geriatric population thus not only indicates the presence of more potential users for medical exoskeletons but also implies that there would be a lesser number of active people to look after the elderly and disabled in the coming years. As a result, the demand for effective rehabilitation approaches, including the use of new and advanced technologies and products, is increasing across the globe. This is considered as a positive indicator for the growth of the medical exoskeleton market in all major regions.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138546702
Impact of Covid-19 on The Medical Exoskeleton Market;
As of September 2021, more than 220 million confirmed cases of COVID-19 were reported globally, with more than 4.5 million deaths (Source: WHO). This situation has compelled governments across the world to take proactive measures to contain the outbreak.
The COVID-19 pandemic had a negative impact on the market in 2020, with small and medium-sized companies struggling to sustain their businesses. The medical exoskeleton market is witnessing a variable growth trend, with some countries offering some growth potential while others are facing closures and low profit margins. Major exoskeleton providers, such as Ekso Bionics, ReWalk Robotics, and Hocoma AG, have incurred a reduction in overall revenue for the fiscal year 2020 due to a decline in the demand for exoskeleton systems. Manufacturers are likely to adjust production to prevent bottlenecks and plan production according to the demand from OEMs. Tier 1 players experienced a decline in revenue in the remaining quarters of 2020. Moreover, medical exoskeleton manufacturers are facing disruptions in supply chains as countries are under lockdown to prevent the spread of the disease.
The hardware segment accounted for the largest share 78.6% of the medical exoskeleton market
The medical exoskeleton market, by component, is segmented into hardware and software. The hardware segment is expected to account for the largest share 78.6% of the medical exoskeleton market in 2020. The dominant share of this segment is attributed to the fact that a large number of parts such as sensors, actuators, power sources, and control systems are required to manufacture exoskeletons.
The lower extremity segment accounted for the largest share 63.0% of the medical exoskeleton market
By extremity, the market is segmented into lower extremity medical exoskeletons and upper extremity medical exoskeletons and Full Body extremity medical exoskeletons. In 2020, the lower extremity medical exoskeletons segment is expected to account for a larger share of 63.0% of the market. Lower extremity exoskeletons provide stability to paralyzed and geriatric patients and offer weight-bearing and locomotion capabilities. As a result, their adoption is higher in the rehabilitation of patients.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=138546702
North America accounted for the largest share 44.4%. of the global medical exoskeleton market
Based on the region, the medical exoskeleton market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2020, North America is expected to dominate the market with a share of 44.4%. The growing geriatric population, increasing demand for self-assist exoskeletons, high prevalence of stroke, and growing number of spinal cord injuries (SCI) are the key factors driving the growth of the medical exoskeleton market in this region.
Some of the leading players in the Medical exoskeleton market include Key players in this market are Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd. (Israel), Parker Hannifin Corp (US), CYBERDYNE Inc. (Japan), Bionik Laboratories Corp (Canada), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (a subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet (Luxembourg).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=138546702
Company Name: MarketsandMarkets Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Address:630 Dundee Road Suite 430
State: IL 60062
Country: United States